Regeneron Pharmaceuticals, Inc.
- Stock
- Ticker REGN
- ISIN US75886F1075
- Nasdaq
Performance, volatility and drawdowns of Regeneron Pharmaceuticals, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $22,940. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −59.7% in 06/2025, measured from the peak in 08/2024. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 3,789 | 3,029 | 3,676 | 3,754 | 3,884 | 3,605 | 4,291 | 5,116 |
| Operating income | 990 | 592 | 1,080 | 1,027 | 880 | 643 | 1,294 | 2,048 |
| EBITDA | 1,117 | 719 | 1,215 | 1,164 | 1,025 | 766 | 1,417 | 2,169 |
| Net income | 918 | 809 | 1,392 | 1,460 | 845 | 727 | 1,297 | 1,949 |
| Earnings per share | 8.11 | 7.27 | 12.81 | 13.62 | 7.87 | 6.75 | 12.23 | 18.45 |
| Balance sheet | ||||||||
| Total assets | 37,759 | 37,545 | 38,219 | 40,169 | 40,559 | 40,869 | 41,731 | 44,405 |
| Liabilities | 8,406 | 8,158 | 8,280 | 9,212 | 9,302 | 9,445 | 10,019 | 10,907 |
| Equity | 29,354 | 29,388 | 29,939 | 30,958 | 31,257 | 31,424 | 31,711 | 33,499 |
| Cash | 2,488 | 3,090 | 1,996 | 2,506 | 3,118 | 2,963 | 2,456 | 3,659 |
| Long-term debt | 1,984 | 1,985 | 1,985 | 1,986 | 1,986 | 1,986 | 1,987 | 1,987 |
| Cash flow | ||||||||
| Operating cash flow | 1,263 | 1,045 | 1,144 | 1,619 | 1,171 | 1,079 | 813 | 1,783 |
| Capital expenditure | -200 | -229 | -219 | -201 | -249 | -231 | -240 | -300 |
| Free cash flow | 1,063 | 816 | 925 | 1,417 | 922 | 848 | 573 | 1,483 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2021 at +30.7%, weakest 2024 at −18.9%. 7 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 30 Oct 2026 | $18.45 |
| 30 Jul 2026 | $12.23 |
| 29 Apr 2026 | $6.75 |
| 4 Feb 2026 | $7.87 |
| 28 Oct 2025 | $13.62 |
| 1 Aug 2025 | $12.81 |
| 29 Apr 2025 | $7.27 |
| 5 Feb 2025 | $8.11 |
| 31 Oct 2024 | $11.54 |
| 1 Aug 2024 | $12.41 |
| 2 May 2024 | $6.27 |
| 5 Feb 2024 | $10.20 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €88bn
- Market cap in trading currency
- $97.2bn
- Enterprise value
- $89.9bn
- P/E
- 20.3
- P/S
- 5.75
- P/B
- 2.90
- EV/Sales
- 5.32
- EV/EBITDA
- 16.7
- Earnings yield
- 4.9%
- FCF yield
- 3.9%
Results (last four quarters)
- Revenue
- $16.9bn
- Gross profit
- –
- EBITDA
- $5.38bn
- Net income
- $4.82bn
- Earnings per share
- $45.30
- Revenue per share
- $160.00
- Revenue growth
- +36.3%
- Earnings growth
- +33.5%
Profitability
- Gross margin
- –
- Operating margin
- 28.8%
- Net margin
- 28.5%
- Return on equity
- 14.9%
- Return on assets
- 10.8%
Balance sheet and cash flow
- Cash
- $9.30bn
- Cash per share
- $88.08
- Financial debt
- $1.99bn
- Debt/equity %
- 6
- Current ratio
- 3.35
- Book value per share
- $317.22
- Operating cash flow
- $4.85bn
- Free cash flow
- $3.83bn
Dividend
- Dividend yield
- 0.40%
- Dividend (12 months)
- $3.70
- Yield (12 months)
- 0.40%
- Payout ratio
- 8%
- Ex-dividend date
- 18 Aug 2026
Shares and trading
- Shares outstanding
- 106m
- Volume
- 855,281
- Avg. volume 3 months
- 802,129
- Relative volume
- 1.1
Price and technicals
- Price
- $920.69
- 1 day
- −0.3%
- 52-week high
- $973.36
- 52-week low
- $600.66
- Distance to 52-week high
- −5.4%
- Distance to 52-week low
- +53.3%
- Distance to 50-day line
- +11.0%
- Distance to 200-day line
- +22.5%
- RSI (14)
- 57
- Volatility 1M
- 54.0%
Performance
- 1 week
- −3.6%
- 1 month
- +12.4%
- 3 months
- +11.1%
- 6 months
- +44.1%
- YTD
- +19.3%
- 1 year
- +31.0%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has REGN performed since 11/2016?
$10,000 grew to $22,940 by 20 Nov 2026, which is +8.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is REGN?
Volatility was 32.0% per year, measured on monthly returns. The largest decline from a peak was −59.7%, with the low in 06/2025.
How does REGN compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, REGN returned +8.7% at 32.0%. The correlation of monthly returns was 0.06; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.